Adil Muneer successfully defended his dissertation under the direction of Dr. Xian Chen on August 25th, 2023, and he has received his PhD. The title of his dissertation is “Non-canonical translation regulatory function of G9a in chronic inflammation associated diseases.”
Xian Chen PhD, Professor of Biochemistry and Biophysics is featured on The Proteomics Show podcast “Road to Chicago” series highlighting speakers at the upcoming US HUPO meeting in Chicago in 2023…
Research: Systems cancer biology and immunology, cancer therapeutic response, protein-protein interaction networks (interactomes), post-translational modifications, epigenetic regulation, signal transduction, disease marker discovery.
Effective August 2, 2019
Research (by Xian Chen and Ling Xie and all authors) has unveiled a crucial role for a protein called PDAP1 in hepatitis A virus infection of the liver. Details of the new discovery were published in Science Advances.
As part of a growing green-lab movement, Carolina competes with labs internationally to cut the high cost of cold storage. Xian Chen’s lab is highlighted for being one of the two labs at UNC who participated in the international challenge!
Xian Chen PhD and Aziz Sancar MD PhD were among those who received grants at the School of Medicine during 9/15/2021 – 9/30/2021.
CRL4DCAF1/VprBP E3 ubiquitin ligase controls ribosome biogenesis, cell proliferation, and development. Authors: Xiao-Ran Han, Naoya Sasaki, Sarah Jackson, Pu Wang, Zhijun Li, Matthew Smith, Ling Xie, Xian Chen, Yanping Zhang, Bill Marzluff and Yue Xiong publishes cell proliferation research in Science Advances.
In the journal Cell Chemical Biology, researchers led by Biochemistry and Biophysics Associate Professor and Faculty Director, Quantitative Proteomics Center for Disease Marker Discovery, Xian Chen, PhD, report on potential prognostic tool that could be used to identify high-risk patients within particular subtypes of breast cancer.
Three scientists at the UNC-CH (Marcey Waters, Brian Strahl, Xian Chen) have received a $1 million grant from the W.M. Keck Foundation’s Medical Research Program to study a widespread but largely unexplored phenomenon that may be implicated in many diseases, including cancer.
Life is full of choices, and even cells come to a fork in the road. They have to decide what to do about damage to their DNA: repair the damage, force the damaged cell to die, or allow the damage to transform the cell to a tumor cell. Read more on the work from the Xian Chen lab in the Department of Biochemistry & Biophysics that was published in Cell Death & Disease.
Thursday, October 15, 2009 — Dr. Xian Chen, Associate Professor of Biochemistry and Biophysics, who along with Dr. Morgan Giddings, Associate Professor of Microbiology and Immunology have been awarded a $1.6 million 2-year “Grand Opportunities” (GO) grant from the National Human Genome Research Institute.
